PROTOCOL OSI-774-206: OPEN-LABEL, PHASE 2 STUDY OF SINGLE-AGENT ERLOTINIB FOR PATIENTS WIT

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences

Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation